United Therapeutics (United States)

Recent papers from United Therapeutics (United States)

1. Conserved recognition and divergent peripheral dynamics of designed statin analogues at human HMG-CoA reductase: ensemble docking and replicated molecular dynamics2026
2. A plain language review of the TETON-1 and TETON-2 studies: inhaled treprostinil (Tyvaso) in idiopathic pulmonary fibrosisExpert Review of Respiratory Medicine · 2026
3. Efficacy and Safety of Upacicalcet in Hemodialysis Patients with Secondary HyperparathyroidismJournal of the American Society of Nephrology · 2026
4. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertensionJournal of the American College of Cardiology · 2002
5. Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine · 2026
6. Hybrid Respiratory Dialysis for Ultra-Low Blood-Flow Extracorporeal CO2 RemovalASAIO Journal · 2026
7. Determination of ETN101, a novel anti-hepatic cancer agent and its two metabolites in rat biological matrices using LC-MS/MS for ADME characterizationFrontiers in Pharmacology · 2026
8. 73 An EGFR-family Signaling Axis Confers Therapeutic Vulnerability in Translocation RCCThe Oncologist · 2026
9. A review of the applied behavioral neuroscience research used to develop the QCore™ tinnitus therapy platformFrontiers in Audiology and Otology · 2026
10. Antimicrobial susceptibility patterns of commensal fecal bacteria isolated from pigs with an intentional genomic alteration that included the selectable marker gene nptIIFrontiers in Microbiology · 2026
11. Residue Interaction Network Reveals Allosteric Pathways Linking Orthosteric and Intracellular Sites in Class A GPCRsJournal of Chemical Information and Modeling · 2026
12. Impact of selumetinib on pain in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas: an in-depth analysis from KOMETNeuro-Oncology Practice · 2026
13. A mechanistic perspective of RNA‑LNP instability and characterization toolboxNucleic Acid Insights · 2026
14. Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 studyThe Lancet · 2026
15. Evidence for Human Thymopoiesis in a Porcine Thymus Graft and T Cell Tolerance to the Source Pig in a Human Recipient of a Thymokidney Xenotransplant 2254531The Journal of Immunology · 2026
16. Ori-TTV particles enable potent in vivo CAR-T cell engineering for the treatment of hematologic malignancies and autoimmune diseases 2256860The Journal of Immunology · 2026
17. First Oral Small-molecule Inhibitors Designed by Generative AI Achieve Biologics-Like Pan-Inhibition of IL-17AA, AF, and FF Dimers 2309250The Journal of Immunology · 2026
18. Coordinated circulating and tissue-based T cell responses precede xenograft rejection 2308959The Journal of Immunology · 2026
19. Preclinical characterization of CLSP-1025, a first-in-class, mutation-specific T-cell engager targeting a neoantigen derived from a common p53 mutationClinical Cancer Research · 2026
20. Food Effects on the Pharmacokinetics of Single Dose and Steady-State Ralinepag, a Novel Oral Prostacyclin Agonist, in Healthy VolunteersAmerican Journal of Cardiovascular Drugs · 2026